We also compared the ER+ breast cancer tissue from bone-metastatic lesions with ER+ primary breast cancer tissue from breast cancer patients without recurrence for 10 years, and with brain and lung metastatic lesions from ER+ breast cancer patients with visceral metastases only, as well as with normal bone tissue. The gene discussed is ESR1; the disease is breast carcinoma.